Products

Abiraterone is a medication that has been developed specifically for the treatment of advanced prostate cancer. It belongs to a class of drugs known as androgen biosynthesis inhibitors. Abiraterone works by blocking the production of androgens, which are male sex hormones that can stimulate the growth of prostate cancer cells.The main use of abiraterone is in the treatment of metastatic castration-resistant prostate cancer (mCRPC). This is a form of prostate cancer that has spread to other parts of the body and is no longer responding to hormonal therapies, such as androgen deprivation therapy (ADT). In these cases, abiraterone can be used in combination with prednisone or prednisolone to slow down the progression of the disease and extend the survival of patients.Abiraterone is typically prescribed after the failure of conventional hormonal therapies. It is administered orally in the form of tablets that are taken once a day on an empty stomach, either in combination with a low-dose glucocorticoid or with food and without a glucocorticoid for patients who have contraindications to glucocorticoids. The medication works by inhibiting an enzyme called CYP17A1, which plays a crucial role in the production of androgens in the adrenal glands, testes, and prostate cancer cells. By reducing the levels of androgens in the body, abiraterone helps to slow down the growth of prostate cancer and alleviate symptoms associated with the disease.Clinical trials have demonstrated the efficacy of abiraterone in improving overall survival and delaying disease progression in patients with mCRPC. It has also shown to be beneficial in reducing prostate-specific antigen (PSA) levels, a marker used to track the progression of prostate cancer. Additionally, abiraterone has been found to improve quality of life and reduce pain in patients with advanced prostate cancer, further highlighting its therapeutic value.As with any medication, abiraterone may cause side effects, which can vary in severity and individual response. Common side effects may include fatigue, hypertension, fluid retention, liver function abnormalities, and musculoskeletal discomfort. Regular monitoring and dose adjustments may be necessary to manage these side effects effectively.In summary, abiraterone is a valuable therapeutic option in the management of advanced prostate cancer. By inhibiting the production of androgens, it helps to slow down the progression of the disease and improve survival outcomes for patients with metastatic castration-resistant prostate cancer. However, it is essential to consult with a healthcare professional to determine the suitability and optimal use of abiraterone in an individual patient's case.